IVI opens Country Office in Austria

Logo PR Newswire
PR Newswire

SEOUL, South Korea, Jan. 25, 2023 /PRNewswire/ -- The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announced today the launch of an IVI Country Office in Austria. This new office signals a step forward for Austria's ambition to dial up efforts in vaccine research and development, and IVI's initiative to work closely with the Austrian government and local research network and biomedical industry.

Dr. Jerome Kim, Director General of IVI, said, "We are thrilled to share that IVI has launched its Austria Country Office in the country's capital, well established in areas of international cooperation and eager to advance its growing R&D ecosystem. In addition to IVI's Europe Regional Office in Stockholm, these two sites will generate joint grant proposals with local partners and mobilize collaborative vaccine R&D projects for global health. We are deeply thankful to the Federal Ministry for European and International Affairs of Austria for supporting the opening of this office."

The Foreign Minister of Austria, Alexander Schallenberg, said, "Austria continues to live up to its reputation as a place of encounter and international dialogue, now also increasingly in the field of vaccine research. The Vienna office will be strengthened by the location of the IVI branch and the contribution of international organizations to value creation in Austria will be increased."

On December 14, 2022, Director General Kim and H.E. Wolfgang Angerholzer, Ambassador of Austria to the Republic of Korea, signed a Seat Agreement at IVI headquarters in Seoul, Republic of Korea, securing IVI's status as an international organization hosted by the Government of Austria.

IVI is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme. 39 countries and the WHO are signatories to IVI's founding treaty, and Austria's application for membership is currently in progress. According to the Federal Ministry for European and International Affairs (BMEIA) of Austria, the government will invest an annual amount of 860,000 euros in IVI, a contribution to Austria's vaccine development in Europe and globally.

The governments of the Republic of Korea, Sweden, India, and Finland currently provide state funding, and Denmark made a core contribution of 4 million Danish kroner in 2022.

Cision View original content:https://www.prnewswire.co.uk/news-releases/ivi-opens-country-office-in-austria-301730047.html

Logo PR Newswire
HealthPress Release2023-03-29 08:07:00
VADUZ, Liechtenstein, March 29, 2023 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body,...

Logo Daily Mail
HealthBy Caitlin Tilley2023-03-29 13:56:39
The World Health Organization (WHO) revised its Covid vaccine recommendations and suggested that healthy children and adolescents may not need a shot. In...

Logo RTTNews
EconomyBy Rtt News Staff Writer2023-03-29 11:02:40
Austria's manufacturing sector deteriorated at the steepest pace in nearly three years, as both output and new orders fell at faster rates, survey data from...

Logo EIN Presswire
Immunodiagnostics Market1 PORTLAND, OR, UNITED STATE, March 28, 2023 / EINPresswire.com / -- Immunodiagnostics Market - Global Outlook and Forecast 2023-2030...

Logo EIN Presswire
HealthPress Release2023-03-29 08:08:20
According to the latest report by IMARC Group, The global immunoglobulin market size reached US$ 14.7 Billion in 2022. UNITED STATES, March 29, 2023 /...

Logo GlobeNewswire
EconomyPress Release2023-03-29 12:30:00
The report "Injection Pen Market, By Product Type (Reusable and Disposable), By Therapy (Diabetes, Fertility, Osteoporosis, Growth Hormone Therapy, and...

Logo GlobeNewswire
TechnologyPress Release2023-03-29 11:30:00
YBS International Berhad Working with Malaysian Financial Institutions and Local Authorities to Fund Equipment Buildout Enovix and YBS International...

Logo PR Newswire
TechnologyPress Release2023-03-28 17:39:00
HOUSTON, March 28, 2023 /PRNewswire/ -- FINBOA, Inc., a leading innovator in intelligent process automation software for financial institutions will be...

Logo PR Newswire
AutoPress Release2023-03-28 16:15:00
LONDON, ON, March 28, 2023 /CNW/ - Industry giant Global Warranty, a leading provider of automotive warranty solutions in Canada, has partnered with AITHR...

Logo PR Newswire
HealthPress Release2023-03-28 07:00:00
GENEVA, Switzerland and AMSTERDAM,The Netherlands, March 28, 2023 /PRNewswire/ -- iOnctura, a clinical stage biotechnology company developing breakthrough...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-29 07:15:00
The two industry leaders will partner to increase access of the world's leading full-sized all-electric motorcycles into existing and new markets alike Zero...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-03-28 15:25:00
Strategic partnership accelerates the development of biologic products for addressing oral tolerance in Hemophilia A and B patients. WALPOLE, Mass., March...

Logo PR Newswire
TechnologyPress Release2023-03-29 14:00:00
The new investment will support SCADAfence's continued growth, and assist in strengthening existing strategic partnerships and extending the platform's reach...

Logo GlobeNewswire
SciencePress Release2023-03-28 12:00:00
Vaxxinity CEO Mei Mei Hu to participate in fireside chat with Sarah Despres, Counselor to the Secretary for Public Health and Science, U.S. Department of...

Logo NewsFileCorp
Press Release2023-03-28 20:29:00
Durham, North Carolina--(Newsfile Corp. - March 28, 2023) - The ISA Global Cybersecurity Alliance (ISAGCA) - a collaborative forum to advance OT...

Logo EIN Presswire
HealthPress Release2023-03-29 09:05:22
Immunoprotein Diagnostic Testing Market Analysis BURLINGAME, CALIFORNIA, UNITED STATES, March 29, 2023 / EINPresswire.com / -- Coherent Market Insights...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-28 00:00:00
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2022 annual...

Logo PR Newswire
TechnologyPress Release2023-03-28 22:00:00
NEW YORK, March 28, 2023 /PRNewswire/ -- Rubenstein Public Relations (RPR) today announced that AIVF, a pioneering reproductive technology company, has...

Logo PR Newswire
TechnologyPress Release2023-03-29 13:39:00
IDENTOS welcomes Peter L. Levin and Jeremy Theal to advisory board TORONTO, March 29, 2023 /CNW/ - IDENTOS Inc., a leader in digital identity and access...

Logo EIN Presswire
HealthPress Release2023-03-29 09:33:29
RNA Vaccines market size was valued at USD 52.5 Bn in 2022 and is expected to expand at a CAGR of 12.80%, reaching USD 169.9 Bn by 2032. NEW YORK CITY, NEW...